Showing 3361-3370 of 9946 results for "".
Close Up With Gil Yosipovitch, MD
https://practicaldermatology.com/columns/physician-spotlight/close-up-with-gil-yosipovitch-md/24002/JAK Inhibitors Make the Cut for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/jak-inhibitors-make-the-cut-for-alopecia-areata/23935/JAK inhibitor approvals increase the opportunity for patients with alopecia areata to experience “life-changing” results.Assessing the Pediatric Dermatology Workforce
https://practicaldermatology.com/topics/pediatric/assessing-the-pediatric-dermatology-workforce/23834/New Products
https://practicaldermatology.com/columns/new-products/new-products-4/23753/DermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weighDermWireTV: Zilxi Launch, Eczema Awareness, Uninsurance Rates
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-zilxi-launch-eczema-awareness-uninsurance-rates/19863/For eczema awareness month, the National Eczema Association (NEA) is offering virtual educational programs, community engagement activities, and additional free resources. Georgia, Oklahoma, and Texas have the highest rates of uninsurance. Zilxi minocycline topical foam launches as new data fromHIFEM Plus Biostimulator for Rounder Buttocks
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hifem-plus-biostimulator-for-rounder-buttocks/23028/A first of its kind device that builds muscle can be combined with long-acting filler for optimal effect.First, Do No Harm
https://practicaldermatology.com/topics/psoriasis/first-do-no-harm/20343/Weighing the data on Cimzia during pregnancy and lactation.Managing Comorbidites of Psoriasis
https://practicaldermatology.com/topics/psoriasis/managing-comorbidites-of-psoriasis/18808/Ron Prussick, MD explains why it's important for dermatologists to discuss the risks of comorbidities such as cardiovascular events, fatty liver disease, depression, and more with patients with psoriasis. While it needs to be determined if the treatments used to treat the outside effects of psoriasiTopical Management of Acne-related Post-inflammatory Hyperpigmentation
https://practicaldermatology.com/topics/general-topics/topical-management-of-acne-related-post-inflammatory-hyperpigmentation/21571/Patient education and continued treatment of underlying acne is essential to ensure optimal outcomes with PIH.